제품 > 항체 > 인산화 특이적 항체

Phospho-MAP2K3-S189 + MAP2K6-S207 Rabbit pAb (AP1112)

Datasheet

Tested applications:WBIHC-PIF/ICCIPChIPChIP-seqRIPFCFC(Intra)ELISAMeDIPNucleotide ArrayDBFACSCoIPCUT&TagmeRIPInhibitionReactivity:Human, Mouse

ABclonal:Western blot - Phospho-MAP2K3-S189 + MAP2K6-S207 Rabbit pAb (AP1112)

Western blot analysis of lysates from NIH/3T3 cells, using Phospho-MAP2K3-S189 + MAP2K6-S207 Rabbit pAb (AP1112) at 1:1000 dilution. NIH/3T3 cells were treated by Anisomycin (25 μg/mL) at 37℃ for 30 minutes after serum-starvation overnight.
Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution.
Lysates/proteins: 25μg per lane.
Blocking buffer: 3% nonfat dry milk in TBST.
Detection: ECL Basic Kit (RM00020).
Exposure time: 180s.

Overview

Product namePhospho-MAP2K3-S189 + MAP2K6-S207 Rabbit pAb
Catalog No.AP1112
Host speciesRabbit
Purification methodAffinity purification
IsotypeIgG
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. [provided by RefSeq, Jul 2008]
ImmunogenA synthetic phosphorylated peptide around S207 of human MAP2K3/MAP2K6MAP2K3 (NP_002747.2).
SequenceVDSVA
Gene ID
Swiss Prot
SynonymsMEK3; MKK3; MAPKK3; PRKMK3; SAPKK2; SAPKK-2
Calculated MW
Observed MW38kDa
ReactivityHuman, Mouse
Tested applicationsWBIHC-PIF/ICCIPChIPChIP-seqRIPFCFC(Intra)ELISAMeDIPNucleotide ArrayDBFACSCoIPCUT&TagmeRIPInhibition
Recommended dilution
  • WB 1:500 - 1:1000
  • ELISA Recommended starting concentration is 1 μg/mL. Please optimize the concentration based on your specific assay requirements.
Storage bufferStore at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.01% thimerosal, 50% glycerol, pH7.3.
Key applicationWestern blotting    
Positive samplesNIH/3T3 treated by Anisomycin
Cellular locationcytosol, nucleoplasm.
    ABclonal:Western blot - Phospho-MAP2K3-S189 + MAP2K6-S207 Rabbit pAb (AP1112)}

    Western blot - Phospho-MAP2K3-S189 + MAP2K6-S207 Rabbit pAb (AP1112)

    Western blot analysis of lysates from NIH/3T3 cells, using Phospho-MAP2K3-S189 + MAP2K6-S207 Rabbit pAb (AP1112) at 1:1000 dilution. NIH/3T3 cells were treated by Anisomycin (25 μg/mL) at 37℃ for 30 minutes after serum-starvation overnight.
    Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution.
    Lysates/proteins: 25μg per lane.
    Blocking buffer: 3% nonfat dry milk in TBST.
    Detection: ECL Basic Kit (RM00020).
    Exposure time: 180s.

    * For research use only. Not for therapeutic or diagnostic purposes.

    항체 (5)

    Secondary Antibodies (26)